These preclinical findings highlighted that abnormal expression of brain RAS is implicated in PD neuropathology, and inhibition of AT1R or ACE by ARBs and ACEIs, respectively, can attenuate the pathogenesis of PD. This evidence concerns the gene AGTR1 and Parkinson disease.